Page last updated: 2024-08-17

quinoxalines and Corneal Diseases

quinoxalines has been researched along with Corneal Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gilbert, DD; Walter, KA1
Barney, NP; Lee, CH; Murphy, CJ; Reid, TW; Taylor, PB; Whiteman, AL1

Other Studies

2 other study(ies) available for quinoxalines and Corneal Diseases

ArticleYear
The adverse effect of perioperative brimonidine tartrate 0.2% on flap adherence and enhancement rates in laser in situ keratomileusis patients.
    Ophthalmology, 2001, Volume: 108, Issue:8

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Brimonidine Tartrate; Corneal Diseases; Corneal Stroma; Female; Humans; Keratomileusis, Laser In Situ; Male; Middle Aged; Ophthalmic Solutions; Preoperative Care; Quinoxalines; Refractive Surgical Procedures; Retrospective Studies; Surgical Flaps; Tissue Adhesions; Visual Acuity

2001
Substance P, insulinlike growth factor 1, and surface healing.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2002, Volume: 120, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Antihypertensive Agents; Brimonidine Tartrate; Corneal Diseases; Drug Therapy, Combination; Epithelium, Corneal; Female; Humans; Insulin-Like Growth Factor I; Keratoplasty, Penetrating; Ophthalmic Solutions; Polymyxin B; Quinoxalines; Substance P; Wound Healing

2002